COMMUNIQUÉS West-GlobeNewswire

Teva Announces FDA Approval and Launch of Generic Saxenda® (liraglutide injection) – First Generic GLP-1 Indicated for Weight Loss
28/08/2025
Generic Saxenda ® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the U.S. market. This approval and launch add to Teva’s continued commitment to [...]
Moleculin Announces Exercise of Warrants for $6.0 Million Gross Proceeds
28/08/2025
HOUSTON, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat [...]
Aprea Therapeutics to Present at H.C. Wainwright Global Investment Conference
28/08/2025
DOYLESTOWN, Pa., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company developing innovative treatments that exploit specific [...]
CytoDyn to Present at the H.C. Wainwright 27th Annual Global Investment Conference
28/08/2025
VANCOUVER, Washington, Aug. 28, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a clinical-stage biotechnology company advancing leronlimab, a first-in-class humanized monoclonal [...]
Streamex (BSGM) to Participate in the 5th Annual Needham Virtual Crypto 1x1 Conference on September 4th
28/08/2025
LOS ANGELES, CA & VANCOUVER, BC , Aug. 28, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (“BioSig” or the “Company”), which recently merged with Streamex Exchange Corporation (“Streamex”) (NASDAQ: BSGM), a gold [...]
Vericel to Present at the Wells Fargo Healthcare Conference on Thursday, September 4, 2025
28/08/2025
CAMBRIDGE, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will [...]
CorMedix to Participate in Upcoming Investor Conferences
28/08/2025
BERKELEY HEIGHTS, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (“CorMedix”) (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening [...]
PolarityBio to Share Regenerative Wound Healing Expertise at SAWC Fall 2025
28/08/2025
SALT LAKE CITY, Aug. 28, 2025 (GLOBE NEWSWIRE) -- PolarityBio , a clinical-stage biotechnology company focused on addressing unmet needs in wound healing through innovation in autologous regenerative skin multicellular [...]
The International Myeloma Foundation Revives ‘Do You #kNOwMyeloma?’ for Blood Cancer Awareness Month 2025
28/08/2025
STUDIO CITY, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- With Blood Cancer Awareness Month coming up this September, the International Myeloma Foundation (IMF) is reviving and amplifying its highly successful #kNOwMyeloma [...]
Can-Fite Reports H1 2025 Financial Results and Clinical Update
28/08/2025
Ramat Gan, Israel, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological [...]
Oculis to Participate in Upcoming September Investor Conferences
28/08/2025
ZUG, Switzerland, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on developing innovative solutions for ophthalmic and neuro- [...]
Oculis to Participate in Upcoming September Investor Conferences
28/08/2025
ZUG, Switzerland, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on developing innovative solutions for ophthalmic and neuro- [...]
TOLREMO therapeutics Receives Two FDA Fast Track Designations for TT125-802 in Pretreated, Advanced or Metastatic NSCLC With Either an EGFR or a KRAS-G12C Mutation
28/08/2025
TT125-802 is a small molecule CBP/p300 bromodomain inhibitor that shows clinical activity as single agent in solid tumors, including advanced EGFR-mutated and KRAS-G12C-mutated non-small cell lung cancer (NSCLC) 1 in 5 [...]
Trading by management and close relations of management
28/08/2025
Please read the announcement in PDF Attachment 2025_41_Trading_By_Management
Idorsia’s TRYVIO – First FDA-approved therapy to target the endothelin pathway for systemic hypertension
28/08/2025
Allschwil, Switzerland – August 28, 2025 Idorsia Ltd (SIX: IDIA) releases an OnDemand investor webcast outlining how TRYVIO™ (aprocitentan) – the first and only hypertension therapy targeting the endothelin pathway – [...]
IBA réalise des résultats solides au premier semestre 2025, évoluant vers une plus haute profitabilité
28/08/2025
Cliquez ici pour lire l'intégralité du communiqué de presse des résultats du premier semestre 2025 Louvain-La-Neuve, Belgique, 28 août 2025 - IBA (Ion Beam Applications S.A.), le leader mondial de la technologie d’ [...]
IBA reports strong Half Year 2025 results, transforming towards a more profitable business
28/08/2025
Read the entire half year 2025 results press release here Louvain-la-Neuve, Belgium, 28 August 2025 - IBA (Ion Beam Applications S.A), the world leader in particle accelerator technology, today announces its [...]
argenx to Present at Upcoming Investor Conferences
28/08/2025
August 28, 2025 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that [...]
International Observers Raise Concerns Over Judicial Irregularities in Senegal; Rights Advocates Stress Importance for Governance and Investment
28/08/2025
Khadim Ba, a Non-Executive Director at DerMond Oil & Gas LOS ANGELES, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Independent legal experts and rights monitors are raising concerns over the ongoing detention and judicial [...]

Pages